Back to 
Bank of New York Mellon Corp
Bank of New York Mellon Corp
CORT
28 quarters
Position history for Bank of New York Mellon Corp's holdings in Corcept Therapeutics Incorporated
Yes. Bank of New York Mellon holds 565,666 shares of CORT (Corcept Therapeutics), worth $49.2M, as of its Q2 2026 13F filing. It increased the position by 21,909 shares (+4.0%) from Q1 2026. Bank of New York Mellon has held CORT in every 13F on record since Q3 2019, 28 quarterly filings.
Current Value
$49.2M
Current Shares
565,666
Total Value Change
+$31.8M
Total Shares Change
-662,157
Quarter-by-Quarter History
Other major holders of CORT: BlackRock, Inc., Vanguard Group Inc.